SLC2A3 and non-small cell lung carcinoma: In addition, gene expression profiling demonstrated that GLUT3 levels were significantly elevated in gemcitabine-sensitive non-small cell lung cancer (NSCLC) cell lines and paclitaxel-sensitive MDA-MB-231 cell lines when compared to their drug-resistant counterparts [18, 19].